Literature DB >> 28575450

Universal attenuators and their interactions with feedback loops in gene regulatory networks.

Dianbo Liu1,2,3, Luca Albergante1,4, Timothy J Newman1.   

Abstract

Using a combination of mathematical modelling, statistical simulation and large-scale data analysis we study the properties of linear regulatory chains (LRCs) within gene regulatory networks (GRNs). Our modelling indicates that downstream genes embedded within LRCs are highly insulated from the variation in expression of upstream genes, and thus LRCs act as attenuators. This observation implies a progressively weaker functionality of LRCs as their length increases. When analyzing the preponderance of LRCs in the GRNs of Escherichia coli K12 and several other organisms, we find that very long LRCs are essentially absent. In both E. coli and M. tuberculosis we find that four-gene LRCs are intimately linked to identical feedback loops that are involved in potentially chaotic stress response, indicating that the dynamics of these potentially destabilising motifs are strongly restrained under homeostatic conditions. The same relationship is observed in a human cancer cell line (K562), and we postulate that four-gene LRCs act as 'universal attenuators'. These findings suggest a role for long LRCs in dampening variation in gene expression, thereby protecting cell identity, and in controlling dramatic shifts in cell-wide gene expression through inhibiting chaos-generating motifs.
© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Year:  2017        PMID: 28575450      PMCID: PMC5499555          DOI: 10.1093/nar/gkx485

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  68 in total

Review 1.  The biological cost of antibiotic resistance.

Authors:  D I Andersson; B R Levin
Journal:  Curr Opin Microbiol       Date:  1999-10       Impact factor: 7.934

2.  Alterations in IRF1/IRF2 expression in acute myelogenous leukemia.

Authors:  H D Preisler; S Perambakam; B Li; W T Hsu; P Venugopal; S Creech; S Sivaraman; N Tanaka
Journal:  Am J Hematol       Date:  2001-09       Impact factor: 10.047

3.  The cost of antibiotic resistance from a bacterial perspective.

Authors:  Johanna Björkman; Dan I. Andersson
Journal:  Drug Resist Updat       Date:  2000-08       Impact factor: 18.500

4.  Attenuation of noise in ultrasensitive signaling cascades.

Authors:  Mukund Thattai; Alexander van Oudenaarden
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

5.  EGR1 target genes in prostate carcinoma cells identified by microarray analysis.

Authors:  J Svaren; T Ehrig; S A Abdulkadir; M U Ehrengruber; M A Watson; J Milbrandt
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

6.  Genes of the GadX-GadW regulon in Escherichia coli.

Authors:  Don L Tucker; Nancy Tucker; Zhuo Ma; John W Foster; Regina L Miranda; Paul S Cohen; Tyrrell Conway
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

7.  Whole-genome discovery of transcription factor binding sites by network-level conservation.

Authors:  Moshe Pritsker; Yir-Chung Liu; Michael A Beer; Saeed Tavazoie
Journal:  Genome Res       Date:  2003-12-12       Impact factor: 9.043

8.  Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia.

Authors:  Christina R Lee; Dave Cervi; Amandine H Truong; You-Jun Li; Aloke Sarkar; Yaacov Ben-David
Journal:  Anticancer Res       Date:  2003 May-Jun       Impact factor: 2.480

9.  Cancer. Addiction to oncogenes--the Achilles heal of cancer.

Authors:  I Bernard Weinstein
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

10.  Sustained loss of a neoplastic phenotype by brief inactivation of MYC.

Authors:  Meenakshi Jain; Constadina Arvanitis; Kenneth Chu; William Dewey; Edith Leonhardt; Maxine Trinh; Christopher D Sundberg; J Michael Bishop; Dean W Felsher
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.